1.
JAMA
; 332(6): 449-450, 2024 08 13.
Article
in English
| MEDLINE
| ID: mdl-39008321
ABSTRACT
This Viewpoint explores a 2023 Biden administration proposal for US agencies to use their march-in rights and the impact this proposed framework could have on drug prices.